Two Sigma Advisers’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$54.1K Sell
2025
Q1
$173K Sell
2024
Q4
$209K Sell
2024
Q3
$411K Sell
2024
Q2
$459K Buy
2024
Q1
$225K Buy
2023
Q4
$67.2K Buy
2022
Q4
Sell
2022
Q3
$89K Sell
2022
Q2
$151K Buy
2022
Q1
$194K Buy
2021
Q4
$167K Buy